177 related articles for article (PubMed ID: 14517167)
21. Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoprotein metabolism. Studies in normal and lipoprotein lipase-inhibited monkeys.
Goldberg IJ; Blaner WS; Vanni TM; Moukides M; Ramakrishnan R
J Clin Invest; 1990 Aug; 86(2):463-73. PubMed ID: 2117022
[TBL] [Abstract][Full Text] [Related]
22. Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice.
Zhong S; Goldberg IJ; Bruce C; Rubin E; Breslow JL; Tall A
J Clin Invest; 1994 Dec; 94(6):2457-67. PubMed ID: 7989603
[TBL] [Abstract][Full Text] [Related]
23. Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes.
Jiang X; Francone OL; Bruce C; Milne R; Mar J; Walsh A; Breslow JL; Tall AR
J Clin Invest; 1996 Nov; 98(10):2373-80. PubMed ID: 8941656
[TBL] [Abstract][Full Text] [Related]
24. Adenoviral vector-mediated overexpression of serum amyloid A in apoA-I-deficient mice.
Webb NR; de Beer MC; van der Westhuyzen DR; Kindy MS; Banka CL; Tsukamoto K; Rader DL; de Beer FC
J Lipid Res; 1997 Aug; 38(8):1583-90. PubMed ID: 9300780
[TBL] [Abstract][Full Text] [Related]
25. Endothelial cell-derived lipase mediates uptake and binding of high-density lipoprotein (HDL) particles and the selective uptake of HDL-associated cholesterol esters independent of its enzymic activity.
Strauss JG; Zimmermann R; Hrzenjak A; Zhou Y; Kratky D; Levak-Frank S; Kostner GM; Zechner R; Frank S
Biochem J; 2002 Nov; 368(Pt 1):69-79. PubMed ID: 12164779
[TBL] [Abstract][Full Text] [Related]
26. Hyperalphalipoproteinemia in human lecithin cholesterol acyltransferase transgenic rabbits. In vivo apolipoprotein A-I catabolism is delayed in a gene dose-dependent manner.
Brousseau ME; Santamarina-Fojo S; Zech LA; Bérard AM; Vaisman BL; Meyn SM; Powell D; Brewer HB; Hoeg JM
J Clin Invest; 1996 Apr; 97(8):1844-51. PubMed ID: 8621767
[TBL] [Abstract][Full Text] [Related]
27. Proteolysis of apolipoprotein A-I by secretory phospholipase A₂: a new link between inflammation and atherosclerosis.
Cavigiolio G; Jayaraman S
J Biol Chem; 2014 Apr; 289(14):10011-23. PubMed ID: 24523407
[TBL] [Abstract][Full Text] [Related]
28. Impact of combined deficiency of hepatic lipase and endothelial lipase on the metabolism of both high-density lipoproteins and apolipoprotein B-containing lipoproteins.
Brown RJ; Lagor WR; Sankaranaravanan S; Yasuda T; Quertermous T; Rothblat GH; Rader DJ
Circ Res; 2010 Aug; 107(3):357-64. PubMed ID: 20558822
[TBL] [Abstract][Full Text] [Related]
29. Evidence that hepatic lipase and endothelial lipase have different substrate specificities for high-density lipoprotein phospholipids.
Duong M; Psaltis M; Rader DJ; Marchadier D; Barter PJ; Rye KA
Biochemistry; 2003 Nov; 42(46):13778-85. PubMed ID: 14622025
[TBL] [Abstract][Full Text] [Related]
30. Regulation of endothelial lipase and systemic HDL cholesterol levels by SREBPs and VEGF-A.
Kivelä AM; Dijkstra MH; Heinonen SE; Gurzeler E; Jauhiainen S; Levonen AL; Ylä-Herttuala S
Atherosclerosis; 2012 Dec; 225(2):335-40. PubMed ID: 23102786
[TBL] [Abstract][Full Text] [Related]
31. AAV gene therapy as a means to increase apolipoprotein (Apo) A-I and high-density lipoprotein-cholesterol levels: correction of murine ApoA-I deficiency.
Vaessen SF; Veldman RJ; Comijn EM; Snapper J; Sierts JA; van den Oever K; Beattie SG; Twisk J; Kuivenhoven JA
J Gene Med; 2009 Aug; 11(8):697-707. PubMed ID: 19431216
[TBL] [Abstract][Full Text] [Related]
32. ApoA-II maintains HDL levels in part by inhibition of hepatic lipase. Studies In apoA-II and hepatic lipase double knockout mice.
Weng W; Brandenburg NA; Zhong S; Halkias J; Wu L; Jiang XC; Tall A; Breslow JL
J Lipid Res; 1999 Jun; 40(6):1064-70. PubMed ID: 10357838
[TBL] [Abstract][Full Text] [Related]
33. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of apolipoprotein O does not impact on plasma HDL levels or functionality in human apolipoprotein A-I transgenic mice.
Nijstad N; de Boer JF; Lagor WR; Toelle M; Usher D; Annema W; der Giet Mv; Rader DJ; Tietge UJ
Biochim Biophys Acta; 2011 Apr; 1811(4):294-9. PubMed ID: 21296681
[TBL] [Abstract][Full Text] [Related]
35. In vivo interactions of apoA-II, apoA-I, and hepatic lipase contributing to HDL structure and antiatherogenic functions.
Hedrick CC; Castellani LW; Wong H; Lusis AJ
J Lipid Res; 2001 Apr; 42(4):563-70. PubMed ID: 11290828
[TBL] [Abstract][Full Text] [Related]
36. Interleukin 6 stimulates endothelial binding and transport of high-density lipoprotein through induction of endothelial lipase.
Robert J; Lehner M; Frank S; Perisa D; von Eckardstein A; Rohrer L
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2699-706. PubMed ID: 24115033
[TBL] [Abstract][Full Text] [Related]
37. N-Glycosylation regulates endothelial lipase-mediated phospholipid hydrolysis in apoE- and apoA-I-containing high density lipoproteins.
Skropeta D; Settasatian C; McMahon MR; Shearston K; Caiazza D; McGrath KC; Jin W; Rader DJ; Barter PJ; Rye KA
J Lipid Res; 2007 Sep; 48(9):2047-57. PubMed ID: 17545692
[TBL] [Abstract][Full Text] [Related]
38. Selective uptake of HDL cholesteryl esters is active in transgenic mice expressing human apolipoprotein A-I.
Khoo JC; Pittman RC; Rubin EM
J Lipid Res; 1995 Mar; 36(3):593-600. PubMed ID: 7775870
[TBL] [Abstract][Full Text] [Related]
39. Nascent HDL formation by hepatocytes is reduced by the concerted action of serum amyloid A and endothelial lipase.
Wroblewski JM; Jahangiri A; Ji A; de Beer FC; van der Westhuyzen DR; Webb NR
J Lipid Res; 2011 Dec; 52(12):2255-2261. PubMed ID: 21957202
[TBL] [Abstract][Full Text] [Related]
40. Helper-dependent adenoviral vector-mediated long-term expression of human apolipoprotein A-I reduces atherosclerosis in apo E-deficient mice.
Pastore L; Belalcazar LM; Oka K; Cela R; Lee B; Chan L; Beaudet AL
Gene; 2004 Mar; 327(2):153-60. PubMed ID: 14980712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
